Free Trial

Climb Bio (CLYM) Short Interest Ratio & Short Volume

Climb Bio logo
$1.98 -0.06 (-2.94%)
As of 10/3/2025 04:00 PM Eastern

Climb Bio Short Interest Data

Climb Bio (CLYM) has a short interest of 879,000 shares, representing 1.50% of the float (the number of shares available for trading by the public). This marks a -27.36% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.6, indicating that it would take 1.6 days of the average trading volume of 429,417 shares to cover all short positions.

Current Short Interest
879,000 shares
Previous Short Interest
1,210,000 shares
Change Vs. Previous Month
-27.36%
Dollar Volume Sold Short
$1.79 million
Short Interest Ratio
1.6 Days to Cover
Last Record Date
September 15, 2025
Outstanding Shares
67,764,000 shares
Float Size
58,650,000 shares
Short Percent of Float
1.50%
Today's Trading Volume
1,536,679 shares
Average Trading Volume
429,417 shares
Today's Volume Vs. Average
358%
Short Selling Climb Bio?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Climb Bio and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

CLYM Short Interest Over Time

CLYM Days to Cover Over Time

CLYM Percentage of Float Shorted Over Time

Climb Bio Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
9/15/2025879,000 shares $1.79 million -27.4%1.5%1.6 $2.04
8/31/20251,210,000 shares $2.70 million No Change2.1%2.4 $2.23

CLYM Short Interest - Frequently Asked Questions

What is Climb Bio's current short interest?

Short interest is the volume of Climb Bio shares that have been sold short but have not yet been covered or closed out. As of September 15th, traders have sold 879,000 shares of CLYM short. 1.50% of Climb Bio's shares are currently sold short. Learn More on Climb Bio's current short interest.

What is a good short interest ratio for Climb Bio?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLYM shares currently have a short interest ratio of 2.0. Learn More on Climb Bio's short interest ratio.

What is a good short interest percentage for Climb Bio?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.50% of Climb Bio's floating shares are currently sold short.

Is Climb Bio's short interest increasing or decreasing?

Climb Bio saw a drop in short interest in the month of September. As of September 15th, there was short interest totaling 879,000 shares, a drop of 27.4% from the previous total of 1,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Climb Bio's float size?

Climb Bio currently has issued a total of 67,764,000 shares. Some of Climb Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Climb Bio currently has a public float of 58,650,000 shares.

How does Climb Bio's short interest compare to its competitors?

1.50% of Climb Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Climb Bio: Olema Pharmaceuticals, Inc. (12.01%), Oruka Therapeutics, Inc. (10.00%), Arvinas, Inc. (13.06%), Arcturus Therapeutics Holdings Inc. (23.93%), Erasca, Inc. (11.57%), Aquestive Therapeutics, Inc. (8.90%), Eton Pharmaceuticals, Inc. (16.06%), COMPASS Pathways PLC Sponsored ADR (7.01%), Inventiva S.A. Sponsored ADR (0.07%), Bicycle Therapeutics PLC Sponsored ADR (2.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Corporation ($8.81 billion), Canadian Natural Resources Limited ($5.82 billion), Reddit Inc. ($5.19 billion), Coinbase Global, Inc. ($4.52 billion), Robinhood Markets, Inc. ($4.30 billion), Charter Communications, Inc. ($3.75 billion), CoreWeave Inc. ($3.66 billion), Seagate Technology Holdings PLC ($3.57 billion), Live Nation Entertainment, Inc. ($3.33 billion), and Rocket Lab Corporation ($3.26 billion). View all of the most shorted stocks.

What does it mean to sell short Climb Bio stock?

Short selling CLYM is an investing strategy that aims to generate trading profit from Climb Bio as its price is falling. CLYM shares are trading down $0.06 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Climb Bio?

A short squeeze for Climb Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLYM, which in turn drives the price of the stock up even further.

How often is Climb Bio's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLYM, twice per month. The most recent reporting period available is September, 15 2025.




This page (NASDAQ:CLYM) was last updated on 10/4/2025 by MarketBeat.com Staff
From Our Partners